REIT - Industrial
Compare Stocks
2 / 10Stock Comparison
NHPAP vs CTRE
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
NHPAP vs CTRE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Industrial | REIT - Healthcare Facilities |
| Market Cap | $592M | $8.82B |
| Revenue (TTM) | $348M | $468M |
| Net Income (TTM) | $-80M | $335M |
| Gross Margin | 36.2% | 86.8% |
| Operating Margin | -4.2% | 69.1% |
| Forward P/E | — | 26.6x |
| Total Debt | $1.15B | $894M |
| Cash & Equiv. | $22M | $198M |
NHPAP vs CTRE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| National Healthcare… (NHPAP) | 100 | 114.8 | +14.8% |
| CareTrust REIT, Inc. (CTRE) | 100 | 212.1 | +112.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NHPAP vs CTRE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NHPAP is the clearest fit if your priority is momentum.
- +60.6% vs CTRE's +40.3%
CTRE carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.14, yield 3.2%
- Rev growth 108.8%, EPS growth 96.3%, 3Y rev CAGR 36.5%
- 265.1% 10Y total return vs NHPAP's 30.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 108.8% FFO/revenue growth vs NHPAP's 2.3% | |
| Quality / Margins | 71.5% margin vs NHPAP's -23.0% | |
| Stability / Safety | Beta 0.14 vs NHPAP's 0.17, lower leverage | |
| Dividends | 3.2% yield, 2-year raise streak, vs NHPAP's 2.3% | |
| Momentum (1Y) | +60.6% vs CTRE's +40.3% | |
| Efficiency (ROA) | 6.7% ROA vs NHPAP's -4.6%, ROIC 6.1% vs -4.8% |
NHPAP vs CTRE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NHPAP vs CTRE — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CTRE leads this category, winning 5 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
CTRE and NHPAP operate at a comparable scale, with $468M and $348M in trailing revenue. CTRE is the more profitable business, keeping 71.5% of every revenue dollar as net income compared to NHPAP's -23.0%. On growth, CTRE holds the edge at +99.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $348M | $468M |
| EBITDAEarnings before interest/tax | $72M | $428M |
| Net IncomeAfter-tax profit | -$80M | $335M |
| Free Cash FlowCash after capex | -$125M | $400M |
| Gross MarginGross profit ÷ Revenue | +36.2% | +86.8% |
| Operating MarginEBIT ÷ Revenue | -4.2% | +69.1% |
| Net MarginNet income ÷ Revenue | -23.0% | +71.5% |
| FCF MarginFCF ÷ Revenue | -35.9% | +85.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.9% | +99.3% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +2.9% |
Valuation Metrics
NHPAP leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $592M | $8.8B |
| Enterprise ValueMkt cap + debt − cash | $1.7B | $9.5B |
| Trailing P/EPrice ÷ TTM EPS | -2.91x | 25.17x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 26.58x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.19x |
| EV / EBITDAEnterprise value multiple | — | 23.03x |
| Price / SalesMarket cap ÷ Revenue | 1.67x | 18.51x |
| Price / BookPrice ÷ Book value/share | 0.86x | 2.00x |
| Price / FCFMarket cap ÷ FCF | — | 23.27x |
Profitability & Efficiency
CTRE leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
CTRE delivers a 8.6% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-12 for NHPAP. CTRE carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to NHPAP's 1.67x. On the Piotroski fundamental quality scale (0–9), CTRE scores 5/9 vs NHPAP's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -12.3% | +8.6% |
| ROA (TTM)Return on assets | -4.6% | +6.7% |
| ROICReturn on invested capital | -4.8% | +6.1% |
| ROCEReturn on capital employed | -7.7% | +7.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 |
| Debt / EquityFinancial leverage | 1.67x | 0.22x |
| Net DebtTotal debt minus cash | $1.1B | $696M |
| Cash & Equiv.Liquid assets | $22M | $198M |
| Total DebtShort + long-term debt | $1.1B | $894M |
| Interest CoverageEBIT ÷ Interest expense | -1.78x | 8.44x |
Total Returns (Dividends Reinvested)
CTRE leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CTRE five years ago would be worth $19,660 today (with dividends reinvested), compared to $12,266 for NHPAP. Over the past 12 months, NHPAP leads with a +60.6% total return vs CTRE's +40.3%. The 3-year compound annual growth rate (CAGR) favors CTRE at 29.6% vs NHPAP's 12.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +18.1% | +9.9% |
| 1-Year ReturnPast 12 months | +60.6% | +40.3% |
| 3-Year ReturnCumulative with dividends | +42.0% | +117.8% |
| 5-Year ReturnCumulative with dividends | +22.7% | +96.6% |
| 10-Year ReturnCumulative with dividends | +30.2% | +265.1% |
| CAGR (3Y)Annualised 3-year return | +12.4% | +29.6% |
Risk & Volatility
CTRE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CTRE is the less volatile stock with a 0.14 beta — it tends to amplify market swings less than NHPAP's 0.17 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.17x | 0.14x |
| 52-Week HighHighest price in past year | $22.17 | $41.72 |
| 52-Week LowLowest price in past year | $13.42 | $27.72 |
| % of 52W HighCurrent price vs 52-week peak | +94.4% | +94.7% |
| RSI (14)Momentum oscillator 0–100 | 60.6 | 54.5 |
| Avg Volume (50D)Average daily shares traded | 9K | 2.5M |
Analyst Outlook
CTRE leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
For income investors, CTRE offers the higher dividend yield at 3.22% vs NHPAP's 2.33%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $42.50 |
| # AnalystsCovering analysts | — | 19 |
| Dividend YieldAnnual dividend ÷ price | +2.3% | +3.2% |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | $0.49 | $1.27 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.0% |
CTRE leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NHPAP leads in 1 (Valuation Metrics).
NHPAP vs CTRE: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is NHPAP or CTRE a better buy right now?
For growth investors, CareTrust REIT, Inc.
(CTRE) is the stronger pick with 108. 8% revenue growth year-over-year, versus 2. 3% for National Healthcare Properties, Inc. (NHPAP). CareTrust REIT, Inc. (CTRE) offers the better valuation at 25. 2x trailing P/E (26. 6x forward), making it the more compelling value choice. Analysts rate CareTrust REIT, Inc. (CTRE) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — NHPAP or CTRE?
Over the past 5 years, CareTrust REIT, Inc.
(CTRE) delivered a total return of +96. 6%, compared to +22. 7% for National Healthcare Properties, Inc. (NHPAP). Over 10 years, the gap is even starker: CTRE returned +265. 1% versus NHPAP's +30. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — NHPAP or CTRE?
By beta (market sensitivity over 5 years), CareTrust REIT, Inc.
(CTRE) is the lower-risk stock at 0. 14β versus National Healthcare Properties, Inc. 's 0. 17β — meaning NHPAP is approximately 26% more volatile than CTRE relative to the S&P 500. On balance sheet safety, CareTrust REIT, Inc. (CTRE) carries a lower debt/equity ratio of 22% versus 167% for National Healthcare Properties, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — NHPAP or CTRE?
By revenue growth (latest reported year), CareTrust REIT, Inc.
(CTRE) is pulling ahead at 108. 8% versus 2. 3% for National Healthcare Properties, Inc. (NHPAP). On earnings-per-share growth, the picture is similar: CareTrust REIT, Inc. grew EPS 96. 3% year-over-year, compared to -136. 5% for National Healthcare Properties, Inc.. Over a 3-year CAGR, CTRE leads at 36. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — NHPAP or CTRE?
CareTrust REIT, Inc.
(CTRE) is the more profitable company, earning 67. 3% net margin versus -53. 6% for National Healthcare Properties, Inc. — meaning it keeps 67. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTRE leads at 67. 2% versus -34. 9% for NHPAP. At the gross margin level — before operating expenses — CTRE leads at 59. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — NHPAP or CTRE?
All stocks in this comparison pay dividends.
CareTrust REIT, Inc. (CTRE) offers the highest yield at 3. 2%, versus 2. 3% for National Healthcare Properties, Inc. (NHPAP).
07Is NHPAP or CTRE better for a retirement portfolio?
For long-horizon retirement investors, CareTrust REIT, Inc.
(CTRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 14), 3. 2% yield, +265. 1% 10Y return). Both have compounded well over 10 years (CTRE: +265. 1%, NHPAP: +30. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between NHPAP and CTRE?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NHPAP is a small-cap quality compounder stock; CTRE is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.